Oral Presentation at EULAR 2024 of Data from Global Phase 2b Clinical Trial Demonstrates Durability of Pain Relief After a Single Injection of MM-II in Patients with Painful Knee Osteoarthritis (OA)

A single intra-articular injection of 3mL of MM-II provided greater pain relief than placebo for up to 26 weeks From weeks 12 to 26, more patients on MM-II experienced a ≥50% improvement in knee OA pain than patients on placebo and used less rescue medication MUMBAI, India and TEL AVIV,…